Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 33 AND POTASSIUM CHLORIDE 0 075 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 33 AND POTASSIUM CHLORIDE 0 075 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER.
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER vs MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose 5% provides free water and calories for cellular metabolism, with glucose being the primary energy source. Sodium chloride 0.33% restores sodium and chloride ions to maintain extracellular fluid osmolality and acid-base balance. Potassium chloride 0.075% replenishes potassium, essential for nerve conduction, muscle contraction, and enzymatic reactions.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Intravenous infusion. Dose determined by fluid, electrolyte, and caloric requirements. Typical adult dose: 500-1000 mL as a single infusion at a rate of 100-200 mL/hour, based on clinical status.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
None Documented
None Documented
Dextrose: <15 minutes (rapid cellular uptake and metabolism). Electrolytes: sodium and chloride have no defined half-life due to rapid distribution and renal regulation; potassium half-life approximately 1-1.5 hours in plasma following intravenous administration.
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Dextrose: nearly completely metabolized to CO2 and water, with <1% excreted unchanged in urine. Sodium and chloride: primarily excreted renally, with >90% of filtered load reabsorbed; excretion varies with dietary intake and homeostatic mechanisms. Potassium: >90% excreted renally, with the remainder in feces and sweat.
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Category A/B
Category C
Electrolyte
Electrolyte